Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8
July 20 2022 - 4:00PM
Business Wire
Clovis Oncology, Inc. (NASDAQ: CLVS) will
announce its second quarter 2022 financial results and provide an
update on its clinical development programs and regulatory and
business outlook on Monday, August 8, 2022, before the open of the
US financial markets. Clovis’ senior management will host a
conference call and live audio webcast at 6:30am ET to discuss
Clovis’ results and business outlook in greater detail.
The conference call will be simultaneously webcast on the Clovis
Oncology website www.clovisoncology.com, and a replay of the
webcast will be available for 30 days.
Dial-in numbers for the conference call are as follows: US
participants 888.440.4615 International participants 646.960.0682,
conference ID: 2259685.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing, and commercializing innovative anti-cancer
agents in the US, Europe, and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops with partners
diagnostic tools intended to direct a compound in development to
the population that is most likely to benefit from its use. Clovis
Oncology is headquartered in Boulder, Colorado; please visit
www.clovisoncology.com for more information, including additional
office locations in the US and Europe.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220720005107/en/
Clovis Investor Contacts: Anna Sussman 303.625.5022
asussman@clovisoncology.com
Breanna Burkart 303.625.5023 bburkart@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Sep 2023 to Sep 2024